Timed sequential induction chemotherapy in AML: time for reflection.
Stone
Richard
R
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. rstone@partners.org
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D002454:Cell Differentiation / Q000187:drug effects; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D004334:Drug Administration Schedule; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction / Q000379:methods
D000964:Antimetabolites, Antineoplastic